INSIGHTS ON DRUG DEVELOPMENT

• Suitability Testing For IVT mRNA Analysis

  Automated capillary electrophoresis provides robust, precise analysis of IVT mRNA integrity, concentration, and size, demonstrating excellent method precision.

• Manufacturing Readiness Is The Next Frontier In Life Sciences AI

  As AI compresses discovery timelines, molecules reach commercial manufacturing sooner and with less runway. Readiness starts upstream, where process knowledge transfers and execution data becomes the foundation for trustworthy AI.

• Particles In High Concentration Biotherapeutics

  Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.

• Episodic Vs. Continuous Readiness: Which Operating Model Is Carrying Your Biotech Forward?

  Transitioning from episodic audit prep to continuous readiness protects clinical timelines. Evaluate your quality operating model to support scalable growth today.

• How To Power MRD Assessment And Multi-Cancer Detection Research

  6/25/2026

  New advances in MCED and MRD monitoring are transforming cancer care. Fueled by NGS insights, see how these approaches are shifting treatment decisions toward more proactive strategies.

• The Simplest, Most Powerful Digital PCR Workflow Family

  3/26/2026

  Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.

• ITC For Binding Characterization In Pharmaceutical Research

  4/24/2025

  Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.

• A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics

  11/7/2025

  Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.

• How The Accelerator™ Drug Development Model Enhances eNPV

  2/25/2026

  Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.